Clinical Trial Update: Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Fruquintinib plus capecitabine versus capecitabine as maintenance therapy after first-line chemotherapy in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer, Colorectal Cancer Stage IV | Phase 2 | Status: UNKNOWN